This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

Primary objective

To learn more about the pharmacology of pitavastatin by characterizing the dose‐related effect and variability of the effect of pitavastatin on the surrogate marker: low‐density lipoprotein (LDL cholesterol). The effects of statins on morbidity and mortality is not the objective of this systematic review.

Secondary objectives

To characterize the dose‐related effect and variability of effect of pitavastatin on the surrogate markers: total cholesterol, high‐density lipoprotein (HDL cholesterol), and triglycerides.

To quantify the effect of various doses of pitavastatin on withdrawals due to adverse effects.